The Brown University Geriatric Psychopharmacology Update articles from October 2007

The Brown University Geriatric Psychopharmacology Update archives from October 2007

Latest update on antipsychotic use in elderly dementia patients.(ACNP White Paper)
October 1, 2007... precis * Newly released White Paper from the American College of Neuropsychopharmacology reviews pharmacological and alternative treatments for psychosis and/or agitation in elderly dementia patients, and offers recommendations for...

Bone loss and lower bone density associated with SSRI use in the elderly.(Adverse Events)(serotonin reuptake inhibitor)(Brief article)
October 1, 2007... precis * Two studies examined the association between selective serotonin reuptake inhibitor (SSRI) use and bone loss or loss of density in a senior population; the Osteoporotic Fractures in Men Study examined 5,595 men 65 years and older,...

Legislation introduced to address suicide prevention for seniors.(Legislative Watch)(Stop Senior Suicide Act )
October 1, 2007... Mental health, aging and suicide prevention advocates and consumers groups are applauding legislation introduced recently to help prevent suicide among older adults, an age group they say is particularly vulnerable to this preventable health...

Long-term use of donepezil may be safe and effective in elderly AD patients.(What's New in Research)(alzheimer's disease)
October 1, 2007... precis * Long-term use of donepezil appears to be safe and effective in elderly patients with mild to moderate AD, but benefits can be rapidly lost when treatment is interrupted * 2-phase study of 579 AD patients (mean age 71 years)...

Tai chi for preventing falls in the elderly.(News Notes)(Brief article)
October 1, 2007... Participating in tai chi classes once a week may help to prevent falls in healthy, elderly community-dwelling adults, according to a new study. A controlled trial was carried out in relatively healthy older adults (mean age 69 years) who were...

Switching to a generic may trigger symptom relapse.(News Notes)(Brief article)
October 1, 2007... Switching from a brand name drug to its generic could result in symptom relapse. In a Canadian study to examine the potential risks of switching from Celexa to generic citalopram, 20 patients at an Anxiety Disorders Clinic in Montreal who were...

Sertraline for late-onset pedophilia.(Case Report)(Zoloft)(Case study)
October 1, 2007... Patient: Male, 70 years old Medication: Sertraline (Zoloft) Case: A 70-year-old man presented with late-onset pedophilia involving sexual activity with 6- to 7-year-old girls. During the last 13 years, the patient had given money to...

First-time generic approval for paroxetine (Paxil).(From the FDA)(Mylan Pharmaceuticals Inc.)(Brief article)
October 1, 2007... The FDA has granted first-time generic approval to Mylan Pharmaceuticals for extended-release paroxetine tablets (12.5 mg and 25 mg) for the treatment of major depressive disorder, panic disorder, and premenstrual dysphoric disorder. The...

Approvable letter on Requip (ropinirole) extended-release tablets.(From the FDA)(GlaxoSmithKline PLC)(Brief article)
October 1, 2007... GlaxoSmithKline has received an approvable letter from the FDA for Requip-CR Extended-Release Tablets for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS). Requip-CR is an investigational extended-release formulation...